Columbia Labs Sued Over Drug-Related Stock Drop

Law360, New York (February 3, 2012, 7:53 PM EST) -- Pharmaceutical company Columbia Laboratories Inc., whose touted premature-birth-preventing drug recently failed to win a key U.S. approval, was hit with a class action Friday by an investor who claims he was misled by the company's early hype.

Investor Floyd Wright says that the company, its CEO and other executives inflated the price of Columbia's stock by touting vaginal gel Prochieve as a drug that could help cut the number of premature births — a problem the company said affects more than 10 percent of pregnancies and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

WRIGHT v. COLUMBIA LABORATORIES, INC. et al


Case Number

2:12-cv-00614

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Faith S. Hochberg

Date Filed

January 31, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.